1.Treatment of Erythroplasia of Queyrat with Topical 5 % 5 - Fluorouracil Cream under Occlusion.
Chong Seong LEE ; Hyun Hee KOH ; Kwang Joong KIM ; Eil Soo LEE
Korean Journal of Dermatology 1986;24(4):537-540
We herein reported a typical case of erythroplasia of Queyrat in a 35-year-old male patient who had a 6 month-duration of a erythroplastic lesion on the glans penis and coronal sulcus. He was treated 5% 5-fluorouracil cream under occlusion twice a day for 10 days. Three months after treatment, no erythroplastic lesion was found and rebiopsy showed marked improvement histopathologically.
Adult
;
Erythroplasia*
;
Fluorouracil*
;
Humans
;
Male
;
Penis
2.Overview of symptoms, pathogenesis, diagnosis, treatment, and prognosis of various acquired polyneuropathies.
Hanyang Medical Reviews 2017;37(1):34-39
Polyneuropathy includes a lot of diseases damaging peripheral nerves. It shows roughly the same areas on both sides of the body, featuring weakness, numbness, and burning pain. Polyneuropathy is known to usually begin in the hands and feet and progress to the arms and legs. Sometimes it can involve other parts of the body such as the autonomic nervous system. Lots of causes can induce acute or chronic polyneuropathy, so finding the original cause is most important for the treatment of polyneuropathy. There are too many different types of polyneuropathies to be discussed in this review, so we will discuss some of various acquired polyneuropathies such as diabetic neuropathy, vasculitic neuropathy, alcoholic neuropathy, Vitamin B12 deficiency neuropathy, and drug-induced neuropathy, with special focus on symptoms, pathogenesis, diagnosis, treatment, and prognosis.
Alcoholic Neuropathy
;
Arm
;
Autonomic Nervous System
;
Burns
;
Diabetic Neuropathies
;
Diagnosis*
;
Foot
;
Hand
;
Hypesthesia
;
Leg
;
Peripheral Nerves
;
Polyneuropathies*
;
Prognosis*
;
Vitamin B 12 Deficiency
3.The role of PI3K/AKT pathway and its therapeutic possibility in Alzheimer's disease.
Hanyang Medical Reviews 2017;37(1):18-24
Alzheimer's disease (AD) is the most common form of dementia. Although uncountable clinical trials have been done to develop the treatment of AD, there are a couple of drugs that can be used only for symptomatic treatment. Therefore, many studies based on the amyloid cascade hypothesis and the tauopathy hypothesis are still ongoing. After the failure of numerous huge Phase III clinical trials, arguments on those hypotheses have arisen and efforts to establish other possible therapeutic strategies based on diverse plausible mechanisms associated with AD have been done as well. One of the new therapeutic targets for AD is the phosphatidylinositol 3-kinase (PI3K)/AKT pathway. In this review, questions on the two hypotheses, the definition of the PI3K/AKT pathway, the relationship between the pathway and AD, and the possibility of the modulation of the pathway as a new therapeutic strategy for AD will be discussed briefly.
Alzheimer Disease*
;
Amyloid
;
Dementia
;
Phosphatidylinositol 3-Kinase
;
Tauopathies
4.Is Telomere Length Shortening a Risk Factor for Neurodegenerative Disorders?
Dementia and Neurocognitive Disorders 2022;21(3):83-92
Telomeres are located at the end of chromosomes. They are known to protect chromosomes and prevent cellular senescence. Telomere length shortening has been considered an important marker of aging. Many studies have reported this concept in connection with neurodegenerative disorders. Considering the role of telomeres, it seems that longer telomeres are beneficial while shorter telomeres are detrimental in preventing neurodegenerative disorders. However, several studies have shown that people with longer telomeres might also be vulnerable to neurodegenerative disorders. Before these conflicting results can be explained through large-scale longitudinal clinical studies on the role of telomere length in neurodegenerative disorders, it would be beneficial to simultaneously review these opposing results. Understanding these conflicting results might help us plan future studies to reveal the role of telomere length in neurodegenerative disorders. In this review, these contradictory findings are thoroughly discussed, with the aim to better understand the role of telomere length in neurodegenerative disorders.
5.Rat Models for Ischemic Stroke.
Hyun Young KIM ; Seong Ho KOH ; Seung Hyun KIM
Korean Journal of Stroke 2011;13(3):107-113
Highly reproducible and consistent ischemic stroke models are critical for obtaining more confident data. To date, the infarct variation of several ischemic rat models is considerable. Therefore, many factors related to outcome variation and infarct growth must be controlled. Among various infarct models of rodents, intraluminal filament model is common by virtue of its consistency of the success rate and the outcomes. Recently more long-term evaluation of functional and imaging outcomes is considered in terms of clinical practice. Concise and subsequent outcome assessment could result in the improvement of translational stroke research. We recommend that the researchers should remember the guidelines addressed by the Stroke Therapy Academic Industry Roundtable (STAIR) and the Good Laboratory Practice (GLP).
Animals
;
Rats
;
Rodentia
;
Stroke
;
Virtues
6.A Case of Epidural Abscess Complicated from Acute Mastoiditis Caused by Streptococcus pneumoniae.
Jee Hyun CHOI ; Min Sung KIM ; Jong Hyun KIM ; Byung Chul SON ; Seong Joon KIM ; So Hyun PARK ; Jung Hyun LEE ; Jin Hee OH ; Dae Kyun KOH
Korean Journal of Pediatric Infectious Diseases 2014;21(2):144-149
Acute otitis media (AOM) is one of the most common childhood infectious diseases. Despite antibiotic treatment for AOM, AOM and its complication still continue to develop. Acute mastoiditis is a serious complication of AOM and epidural abscess constitutes the commonest of all intracranial complication of AOM. Neurological complication of acute mastoiditis are rare but can be life threatening. Their presentation may be masked by the use of antibiotics. We report the rare case of acute otitis media progressing to acute mastoiditis, epidural abscess formation and lateral sinus thrombophlebitis caused by Streptococcus pneumoniae in a child. She was admitted with acute otitis media with fever. Despite proper antibiotics, acute mastodititis and epidural abscess were developed, and after surgical drainage and antibiotics therapy she was recovered without sequalae.
Anti-Bacterial Agents
;
Child
;
Communicable Diseases
;
Drainage
;
Epidural Abscess*
;
Fever
;
Humans
;
Lateral Sinus Thrombosis
;
Masks
;
Mastoid*
;
Mastoiditis*
;
Otitis Media
;
Streptococcus pneumoniae*
7.Epilepsy and driving: A survey on the Opinions of Korean Neurologists.
Seong Ho KOH ; Hee Tae KIM ; Juhan KIM ; Seung Hyun KIM ; Myung Ho KIM
Journal of the Korean Neurological Association 2001;19(5):485-488
BACKGROUND: In Korea, the law to restrict epilepsy patients from driving automobiles does not exist. However, the need for a regulatory law is controversial due to conflicting interests of the right to drive and the safety of those on the road. We investigated the opinions of Korean neurologists on this matter. METHODS: 223 neurologists participated in this survey. They answered a questionnaire comprised of 15 questions. RESULTS: The results of the survey are as follows: the regulation should be legislated (94.6%), the decision on the patient's driving must be done by the doctor (83.4%), the patient's driving is reported obligatorily (33.2%), the duration for the restriction should be 24 months (30%), the renewal of the driving license should be done every other year, the escaping rebuke for the reporter is also needed (90.6%), and the draft for the regulation should be composed by the Korean Epilepsy Society (74%). CONCLUSIONS: Many Korean neurologists agree that regulation of epilepsy patients who want to drive is needed. The new regulatory law should include general and individual restrictions based upon the conditions made by the Korean Epilepsy Society and must be accepted by the patients and other members of the society. (J Korean Neurol Assoc 19(5):485~488, 2001)
Automobile Driving
;
Automobiles
;
Epilepsy*
;
Humans
;
Jurisprudence
;
Korea
;
Licensure
;
Surveys and Questionnaires
;
United Nations
8.Identification of Mycobacterium tuberculosis Complex Using a Gene Probe method.
Joon NAH ; Jung Won HUH ; Seong Hee LEE ; Bong Cheol KIM ; Youn Suck KOH ; Chik Hyun PAI
Korean Journal of Clinical Pathology 1997;17(1):71-78
BACKGROUND: Rapid and accurate identification of Mycobacterium tuberculosis complex is important in the diagnosis, treatment, and assessment of prognosis of tuberculosis. But, the conventional identification procedures such as niacin test usually requires considerable time. In this study, we compared the diagnostic value of a gene probe method with that of the niacin test for the differentiation of M. tuberculosis complex from mycobacteria other than tuberculosis (MOTT). METHODS: Commercially available gene probe kit(AccuProbeTM, Gen-Probe, Inc. , San Diego, Calif.) and Niacin test strip were used to identify 78 strains of mycobacteria isolated from patients at Asan Medical Center. One ATCC strain (M. tuberculosis complex) and one MOTT strain were used as controls. Polymerase chain reaction(PCR) was used when the above two tests yielded discordant results. RESULTS: Fifty isolates were identified as M. tuberculosis complex by both gene probe method and niacin test. Likewise 25 isolates were identified as MOTT by the both methods. For the remaining 5 isolates, the results of the two tests differed from each other: M. tuberculosis complex by gene probe and MOTT by niacin test. By PCR, however. these strains were identified as M. tuberculosis. The time required for identification was 1 to 2 hours by gene probe method and 1 to 3 weeks by niacin test. CONCLUSION: Gene probe is simple, rapid and reliable and is a very practical diagnostic tool that can be used in any clinical laboratory.
Chungcheongnam-do
;
Diagnosis
;
Genes, vif*
;
Humans
;
Mycobacterium tuberculosis*
;
Mycobacterium*
;
Niacin
;
Polymerase Chain Reaction
;
Prognosis
;
Tuberculosis
9.Acute Disseminated Encephalomyelitis Following Pneumococcal Vaccination.
Hyun Seung GWAK ; Seong Ho KOH ; Kyu Yong LEE
Journal of the Korean Neurological Association 2016;34(3):256-258
No abstract available.
Encephalomyelitis, Acute Disseminated*
;
Vaccination*
10.Neural Stem Cell Death Mechanisms Induced by Amyloid Beta.
Jongmin LEE ; Hyun Hee PARK ; Seong Ho KOH ; Hojin CHOI
Dementia and Neurocognitive Disorders 2017;16(4):121-127
BACKGROUND AND PURPOSE: Amyloid beta (Aβ) is the main component of amyloid plaques, which are deposited in the brains of patients with Alzheimer's disease (AD). Biochemical and animal studies support the central role of Aβ in AD pathogenesis. Despite several investigations focused on the pathogenic mechanisms of Aβ, it is still unclear how Aβ accumulates in the central nervous system and subsequently initiates the disease at the cellular level. In this study, we investigated the pathogenic mechanisms of Aβ using proteomics and antibody microarrays. METHODS: To evaluate the effect of Aβ on neural stem cells (NSCs), we treated primary cultured cortical NSCs with several doses of Aβ for 48 h. A 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay, trypan blue staining, and bromodeoxyuridine cell proliferation assay were performed. We detected several intracellular proteins that may be associated with Aβ by proteomics and Western blotting analysis. RESULTS: Various viability tests showed that Aβ decreased NSCs viability and cell proliferation in a concentration-dependent manner. Aβ treatment significantly decreased lactate dehydrogenase B, high-mobility group box 1, aldolase C, Ezrin, and survival signals including phosphorylated phosphoinositide 3-kinase, Akt, and glycogen synthase kinase-3β. CONCLUSIONS: These results suggest that several factors determined by proteomics and Western blot hold the clue to Aβ pathogenesis. Further studies are required to investigate the role of these factors.
Alzheimer Disease
;
Amyloid*
;
Animals
;
Blotting, Western
;
Brain
;
Bromodeoxyuridine
;
Cell Proliferation
;
Central Nervous System
;
Fructose-Bisphosphate Aldolase
;
Glycogen Synthase
;
Humans
;
L-Lactate Dehydrogenase
;
Neural Stem Cells*
;
Plaque, Amyloid
;
Proteomics
;
Trypan Blue